iBio (IBIO) Earnings Analysis
iBio (IBIO) next reports earnings on 2026-09-04, consensus EPS -0.07 USD. Last quarter (2025-11-12) it missed with EPS -0.11 USD vs -0.07 USD est (-57.1%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -2.40.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IBIO next report earnings?
| Next earnings date | 2026-09-04 |
|---|---|
| Consensus EPS estimate | -0.07 USD |
| Revenue estimate | 0.00B |
IBIO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-11-12 | -0.11 USD | -0.07 USD | -57.1% | Miss |
| 2025-09-05 | -0.31 USD | -0.39 USD | +20.5% | Beat |
| 2025-05-02 | -0.49 USD | -0.39 USD | -25.6% | Miss |
| 2025-02-10 | -0.48 USD | -0.45 USD | -6.7% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
IBIO valuation and analyst view
| Trailing P/E | -2.40 |
|---|---|
| Trailing EPS | -0.23082 USD |
| Price / book | 2.13 |
| Dividend yield | 0.00% |
| Market cap | 0.02B |
| Analyst consensus | Buy (3 buy / 1 hold / 0 sell) |
| Avg price target | 5 USD |
Related research pages
Frequently asked questions
When is iBio (IBIO)'s next earnings date?
iBio is next scheduled to report on 2026-09-04, with a consensus EPS estimate of -0.07 USD and revenue estimate of 0.00B.
Did IBIO beat earnings last quarter?
In its 2025-11-12 report, IBIO posted EPS of -0.11 USD versus a -0.07 USD estimate — a miss of 57.1%.
What is IBIO's earnings track record?
Over the last 4 reported quarters with consensus data, IBIO beat estimates 1 times (25%).
What is IBIO's current P/E ratio and EPS?
IBIO trades at a trailing P/E of -2.40 on trailing EPS of -0.23081939799331103 USD.
What do analysts rate IBIO?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 5 USD.